Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: InforMax Taps Amersham Exec to Be President, Chairman, and CEO

This update adds background to the original article.

NEW YORK, March 13 - InforMax has named Andrew Whiteley president, chairman, and CEO, the company announced late on Wednesday.

Whiteley takes over from Alex Titomirov, the company's founder, who is resigning from the company immediately, InforMax said in a statement.

InforMax has scheduled a conference call for Thursday at 8:45 a.m. Eastern time to discuss the move.

As GenomeWeb reported in October, Titomirov left his post, and COO James Bernstein, another founder, retired.
Titomirov said at the time that he will step down as CEO as soon as InforMax finds a replacement. Titomirov also said he will remain chairman of the board, but that option was killed in Thursday's announcement.

The recruiting company Heidrick & Struggles was brought in to recruit the new executive, which the company said it hoped to do by the first quarter 2002.

It was right on time. Whiteley, who has sat on InforMax's board since 2000, was previously president of Amersham Biosciences' bioinformatics division.

"Over the next few months, I anticipate working closely with our current and future customers, collaboration partners, management team and employees as we execute and enhance InforMax's business," Whiteley said in the statement.
Bernstein retired as president, COO, and the board of directors on Dec. 31. John Green, executive vice president and CFO of the Bethesda, Md.-based bioinformatics company, assumed COO duties.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.